The murine parotid secretory protein (PSP) gene is expressed selectively at high levels in parotid and sublingual salivary glands. Previously, the transcriptional activity of a PSP mini-gene, called Lama, was shown to be dependent on a 1.5 kb region located 3 kb upstream of the transcription start site. Here, functional studies in transgenic mice demonstrate that this proximal regulatory region has properties of a parotid and sublingual gland specific enhancer. Protein-binding experiments identify multiple sequence-specific binding complexes spanning the entire 1.5 kb enhancer region. Several sequence elements bound specifically by parotid and/or sublingual gland nuclear extracts, including consensus binding elements for previously described transcription factors as well as novel binding elements are located in the proximal enhancer region. A deletion analysis of the enhancer region in transgenic mice identified a core sequence of 700 bp. This region contains five elements bound specifically by nuclear proteins isolated from the PSP-expressing parotid and sublingual glands. Two of these elements, denoted parotid gland element I (PGE I) and sublingual gland element I (SLE I), are novel salivary gland specific binding elements, bound uniquely by parotid and sublingual gland nuclear extracts, respectively.
INTRODUCTION
The murine salivary glands comprise the paired parotid, submandibular and sublingual glands. Saliva, the final product of the salivary glands, is formed by discrete units of terminally differentiated acinar and duct cells. Acinar cells are predominant in the parotid gland and comprise at least 75-85% of the gland (1) . Parotid gland acinar cells are characterized by their cell-restricted expression of unique proteins (2) , including the parotid secretory protein (PSP), which is the most abundantly expressed gene product of the adult mouse parotid gland. The PSP mRNA constitutes ∼10% of total parotid gland mRNA (3, 4) . Relatively lower expression is detected in the sublingual gland (5, 6) .
Mechanisms of salivary gland specific gene regulation is largely unknown. Expression studies in transgenic mice have defined several salivary gland specific enhancer regions (7) , but the nature of individual binding elements within the majority of these regulatory regions has not been characterized. Functional analyses in transgenic mice have revealed that correct salivary gland specific expression of the PSP gene is directed by several regulatory regions (5, 6, 8) . The salivary gland specific activation of the Lama construct, a PSP mini-gene, in transgenic mice is dependent on an upstream region situated between -3.1 and -4.6 kb (5). This construct was expressed in the sublingual gland between 10 and 100% of the expression level observed for the endogenous gene, but only <1% of the endogenous level in the parotid gland, suggesting that the PSP gene is regulated differently in the two glands, although the sublingual and parotid gland mRNAs are transcribed from the same promotor (5) .
Towards an understanding of the molecular basis for regulation of the PSP gene, the nature of the DNA region located between position -3.1 and -4.6 kb relative to the transcription start site has been investigated in more detail. Here, it is shown that these upstream proximal sequences have properties of a parotid and sublingual gland specific enhancer. Multiple nuclear protein complexes that specifically recognize this proximal PSP enhancer are identified, and seven of these are specific to the PSP-expressing parotid and sublingual glands. Five parotid and/or sublingual gland specific binding elements are located by DNase I footprinting within a 700 bp enhancer core region delineated by deletion analysis in transgenic mice. Two of these binding elements, designated parotid gland element I (PGE I) and sublingual gland element I (SLE I), are bound distinctly by unique parotid and sublingual gland specific protein complexes, respectively, and represent novel salivary gland specific binding elements.
MATERIALS AND METHODS

Generation and analysis of transgenic animals
Transgenic founder mice were generated by pronuclear microinjection of DNA constructs in fertilized eggs obtained from a cross between F1(C57BL/6J × DBA/2J) × F1 (C57BL/6J × DBA/2J) as described (9) . Transgenic mice were identified by Southern blotting as described previously (5) .
Northern blotting
Total RNA was isolated from the transgenic progeny of the founder mice by use of the RNA Isolator kit (Genosys) or a small-step version of the single-step method of RNA isolation by *To whom correspondence should be addressed. Tel: +45 8942 2629; Fax: +45 8619 6500; Email: ph@mbio.aau.dk acid guanidium thiocyanate-phenol-chloroform extraction (10) . All analyzed mice were at least six weeks old, to ensure that the endogenous PSP gene was fully active (11) . Total RNA (2-5 µg of sublingual gland RNA and 15-40 µg of parotid gland RNA) was size separated, blotted onto nylon filters and hybridized with a 32 P-end-labelled, transgene-specific 27 base oligonucleotide as previously described (5) . The transfer of RNA from each lane onto the filter was evaluated by hybridization with a probe specific for 28S rRNA (12) . To compare the level of transgene expression with that of the endogenous PSP mRNA, samples obtained from the sublingual glands of transgenic mice were analyzed using as a probe a denatured, [ 32 P]dATP-labelled, 199 bp, PCR-derived cDNA fragment spanning most of exons h and i. Due to the presence of breakdown products from the PSP mRNA in the parotid gland samples, the level of transgene expression in this gland was calculated by comparing expression in the sublingual gland with that of the parotid gland, relative to total RNA (8) . Hybridizations with DNA probes were performed in 7% SDS (w/v), 0.5 M Na 2 HPO 4 (pH 7.2) and 1 mM EDTA (pH 8) at 68_C, and the final stringency in the washing procedure was 1% SDS (w/v), 20 mM Na 2 HPO 4 (pH 7.2) and 1 mM EDTA (pH 8) at 68_C. Quantifications were performed with a PhosphorImager SF apparatus (General Dynamics) and the ImageQuant software, version 3.3.
Preparation of PSP fragments and probes
Fragments used in gel mobility assays and designated P1-P23 (Figs 4C and 5D) and fragments used in the DNase I protection assays (designated A-M in Fig. 5E ) were generated from a 1.5 kb HindIII-StuI fragment in plasmid pUC19 or from subclones containing smaller fragments of the PSP upstream region. All of the probes used in the gel mobility assay and DNase I footprinting analysis were prepared by restriction enzyme digestion and 3′ end-filling using α-[ 32 P]dATP and the large fragment of DNA polymerase I (Klenow fragment). End-labelled and competitor fragments were fractionated by polyacrylamide gel electrophoresis, eluted from gel slices in phenol/TE and TE buffer (1:1) and purified on glass wool columns. Restriction sites in the proximal enhancer region used for fragment preparation: B, BsmI; D, DdeI; F, FokI; Hc, HincI ; H, HinfI; N, NdeI; P, PstI; R, RsaI; Sf, SfiI; S, StyI and T, Tth111I. Double-stranded oligonucleotides were obtained from Stratagene. Top strand of Sp1 oligonucleotide, 5′-GATCGATCGGGGCGG-GGCGATC-3′; NF1/CTF oligonucleotide, 5′-ATTTTGGCTTG-AAGCCAATATG-3′; AP2 oligonucleotide, 5′-GATCGAACTG-ACCGCCCGGGCCCGT-3′ and AP3 oligonucleotide, 5′-CTAG-TGGGACTTTCCACAGATC-3′.
Preparation of nuclear extracts
All manipulations were performed at 4_C or on ice as rapidly as possible. Organs were dissected from freshly sacrified female BALB/cA mice (6-7 weeks of age). Nuclei from mouse salivary glands were isolated according to the method of Schibler et al. (13) with some modifications. Homogenization buffer [0.3 M sucrose in buffer A (60 mM KCl, 15 mM NaCl, 0.15 mM spermine, 0.5 mM spermidine, 14 mM β-mercaptaethanol, 0.5 mM EGTA, 2 mM EDTA, 15 mM HEPES pH 7.5)] and sucrose cushions were stored at -20_C for 1 h and PMSF was added to a final concentration of 0.5 mM just before use. Homogenized tissue (10% w/v) was sedimented through 30% sucrose in buffer A between one and three times until the nuclei pellet was clean. Finally, the nuclei pellet was carefully resuspended in 1 vol nuclear lysis buffer [20 mM HEPES (pH 7.5), 25% (v/v) glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM DTT and 0.5 mM PMSF]. The suspension was gently stirred for 40 min and centrifuged for 30 min in an eppendorf centrifuge (13 000 r.p.m.). The supernatant fraction was designated the nuclear extract and aliquots were stored at -80_C. Dialysis was not performed as this step resulted in a relatively lower binding activity of the extracts. The nuclear extracts typically contained 5-12 µg/µl protein, as determined by the Bio-Rad protein assay. Nuclear extracts from liver and spleen were prepared according to the protocol of Gorski et al. (14) or the protocol described above. No obvious differences regarding the quantity or quality of the extracts prepared by these two procedures were evident. The DNA-binding activities of all nuclear extract preparations were tested in gel retardation assays before further use.
Gel mobility assay
General conditions found to optimize specific protein-DNA interactions are as follows. Nuclear extracts (3-10 µg) were preincubated with 2 µg poly(dI-dC) in total volume of 20 µl containing 10 mM Tris-HCl (pH 7.5), 40 mM NaCl, 1 mM EDTA, 1 mM DTT and 10% glycerol (v/v), for 10 min on ice. Subsequently, 5000-10 000 c.p.m. of end-labelled fragment (0.1-0.5 ng) was added, and binding was allowed for 15 min on ice. Cold competitor DNA was added prior to the addition of the probe. Samples were analyzed by electrophoresis on 5-8% (30:0.8) non-denaturing polyacrylamide gels in 0.5× TBE (45 mM Tris-borate, 1 mM EDTA, pH 8). The gel was run at 80 V for ∼2 h at 4_C. Gels were pre-electrophoresed for X1 h before loading the samples.
DNase I footprinting
DNase I footprinting reactions were generally carried out as follows. Nuclear extracts (20-40 µg) were preincubated with 2 µg of poly(dI-dC) on ice, in a 20 µl reaction mixture containing 10 mM HEPES (pH 7.5), 80 mM NaCl, 0.3 mM MgCl 2 , 12% glycerol (v/v), 0.5 mM EDTA and 0.5 mM DTT for 10 min. Subsequently, 1-2 ng probe (10 000-20 000 c.p.m.) was allowed to complex with nuclear proteins for 20 min. One to three units (adjusted empirically for each fragment and extract) of DNase I (RQ DNase, Promega) was then added directly to the binding reaction. Limited DNase I digestion was carried out on ice for 90 s, and reactions were stopped by the addition of phenol-chloroformisoamyl alcohol (24:24:1). The products of these reactions were ethanol precipitated, dissolved in formamide-loading buffer, heated at 90_C for 5 min and analyzed on 8 M urea (5-8%) denaturing polyacrylamide gels in 1× TBE, followed by autoradiography. G + A markers were prepared according to Muro et al. (15) .
Sequence analysis
The nucleotide sequence of the proximal PSP enhancer is available in the DDBJ/EMBL/GenBank sequence databanks under accession number X68699. The TRANSFAC database (16) 
RESULTS
The PSP upstream regulatory region has properties of a parotid and sublingual gland specific enhancer
To test the enhancer activity of the upstream region situated between -3.1 and -4.6 kb relative to the transcription initiation site, the construct called -S3.1-E6.2/Lama2.5 ( Fig. 1A) was analyzed in transgenic mice. This construct carries the upstream region in an inverted orientation.
In Figure 1B and C it is illustrated that transgenic mice carrying the -S3.1-E6.2/Lama2.5 construct express transgenic mRNA in the parotid and sublingual glands. Transgenic mRNA is detected in two out of four lines in the sublingual glands and in three out of four lines in the parotid glands. The level of mRNA expression ranges from 10 to 60% of the endogenous level of PSP mRNA in the sublingual gland, but it is <1% of the endogenous level of PSP mRNA in the parotid gland. These relative mRNA levels are similar to the transgenic expression levels of the Lama construct (Fig. 1A ) (5), and indicate that the regulatory region functions independent of the orientation relative to the transcription initiation site. Northern blotting analysis of two lines carrying -S3.1-E6.2/Lama2.5 did not reveal expression in the submandibular glands, lachrymal glands, liver, kidney, spleen, heart or brain (Fig. 1D) . Together, these results suggest that the region between -3.1 and -4.6 kb in the PSP gene functions as a proximal sublingual and parotid gland specific enhancer.
The enhancer region is composed of an array of similar and different protein-binding elements
To screen for proximal enhancer sequences capable of interacting with DNA-binding proteins, nuclear extract was prepared from the mouse parotid glands as described in the Materials and Methods, and analyzed for sequence-specific DNA binding in DNase I footprinting and gel retardation assays.
The entire 1.5 kb enhancer region was initially investigated for protection from DNase I digestion in footprinting experiments using the fragments (A-M) outlined in Figure 5E . The resulting footprinted regions are numbered I-XXVIII. A representative autoradiograph of the DNase I protection pattern obtained with end-labelled restriction fragments (probes D and L, Fig. 5E ) covering PSP sequences from -3495 to -3760 relative to the transcription start site is shown in Figure 2 , and the footprinted sequences of the entire enhancer region are presented in Figure 3 . Figure 2 illustrates the presence of several protected regions (XVII-XX) separated by sites of enhanced DNase I sensitivity on fragments D and L upon binding of parotid gland nuclear proteins. Interestingly, the XX region encompasses a 3′ sequence of 9 bp (5′-ATTTTCCAT-3′) with high homology to 3′ sequences (5′-ATTTTCAAT-3′) protected in the very distinct XIX footprinted region. Also, the upstream border of the XX protected region contains a sequence of six nucleotides (5′-ATCCTT-3′) homologous to the 5′ sequences of the XIX footprint (Fig. 3) . These homologous sequence motifs located in footprints XX and XIX represent novel protein-binding sequences not previously described in the literature. Known consensus sites for homeodomain factors as well as octamer binding factors are also located in XIX and XX (Fig. 3) . The sequence homology between the footprinted XIX and XX regions correlate well with results obtained in the gel retardation assay shown in Figure 4B , where it is demonstrated that the two fragments covering these domains (P14 and P16, respectively) are able to compete with one another for protein binding. Thus, XIX and XX are likely to be bound by homologous proteins, or proteins with similar binding specificities.
The parotid gland binding activities involved in the identified DNA-protein interactions spanning the entire 1.5 kb enhancer region were characterized further by cross-competition analyses among the fragments (P1-P23) shown in Figure 4C . The crosscompetition study shown in Figure 4A suggests that the protein(s) responsible for complex-formation on the P20 fragment has sequence-specificities similar to nuclear proteins binding the P2 Figure 3 . Summary of sequences protected by parotid gland nuclear extract in DNase I footprinting assays. The nucleotide sequence (upper strand) of the proximal enhancer region is shown and nuclear protein-binding sites are indicated by boxes. Twenty-eight sites were identified by DNase I footprinting of the entire region using parotid gland nuclear extract. The protected nucleotides represent average boundaries obtained from several experiments using the DNA fragments A-M shown in Figure 5E . Weak protection is illustrated by dashed lines, and arrows indicate hypersensitive sites. Note that protection patterns are illustrated for the upper strand only and regardless of the strand(s) investigated. Homologies to binding sites for known transcription factors were investigated using the Transfac database (16) and are underlined. AP2, activator protein 2; AP3, activator protein 3; bHLH, basic helix-loop-helix protein; C/EBP, CCAAT-enhancer binding protein; CF1, common factor 1; e.c., enhancer core; E2A, immunoglobin E box binding protein; EI1.2, cytomegalovirus immediate early region 1 enhancer element; GH-CSE, growth hormone cell specific element; HC3, mouse immunoglobin heavy chain enhancer element; HRE, hormone response element; NF1, nuclear factor 1; OTF 1, octamer binding protein 1; oct, octamer binding proteins; PE1, parotid element 1; POU-homeo, POU-homeo domain transcription factors; PTF1, pancreas transcription factor 1; PU.1, ets related protein recognizing purine-rich sequence (PU box); PEA3, polyoma enhancer site A3; SIL1, silencer element identified in the chicken lysozyme gene; TCF-1, factor involved in TCRα gene regulation. Sequence homologies in the two footprinted regions XIX and XX, respectively, are indicated by boxes.
fragment. The results of various similar competition assays are summarized in Figure 4C .
Several of the protected regions in the proximal enhancer contain consensus sequences for previously characterized transcription factors, including the two activator proteins AP2 and AP3 (Fig. 3) , suggesting that known nuclear factors might be involved in some of the identified DNA-protein complexes. The sequence-specificity of nuclear proteins interacting with potential AP2 and AP3 binding sequences in the enhancer region was investigated in more detail. Oligonucleotides containing consensus binding sites for the two activator proteins AP2 and AP3 were able to specifically abolish or diminish several of the DNA-protein interactions identified in the enhancer region (Fig. 4A and data not shown), and a summary of competition for specific protein binding by these consensus elements using the gel retardation assay is shown in Figure 4D . Thus, these competition studies verify specificity of protein-binding to fragments indicated in Figure 4D , and also suggest that known nuclear factors like AP2 and AP3 bind the proximal PSP enhancer region.
Together, these parotid gland protein-binding experiments suggest that the enhancer region is composed of a combination of different and similar protein-binding elements, including known as well as potentially novel binding elements for sequence specific nuclear factors.
Parotid and sublingual gland specific as well as general protein complexes bind the enhancer region
To delimit potential regulatory DNA elements selectively recognized by DNA-binding proteins isolated from the PSPexpressing parotid and sublingual glands, additional protein extracts were prepared from nuclei isolated from mouse sublingual Protein binding to the P16 fragment was studied in the presence of molar excess of the P14 fragment, lanes 3-5 (×10, 50 and 100), P16 fragment, lanes 6-8 (×10, 50 and 100) or NF1/CAAT consensus oligonucleotide, lanes 9-11 (×10, 50 and 100). (C) Summary of cross-competition analyses using fragments P1-P23. Fragments able to compete for parotid gland complex formation are indicated below the fragment used as probe in a gel retardation assay. (++), indicates that the competitor fragment completely inhibited complex formation, whereas (+), indicates that complex formation was diminished. (+/-) indicates that complex formation was altered in the presence of the indicated fragment. Asterisks (*) symbolize that competition was restricted to distinct complexes e.g. one out of two complexes. (D) Summary of competition studies using consensus AP2, AP3 and Sp1 binding sites as competitors in gel retardation assays. See (C) for details. ( §), complex formation was only successful when the competitor was present at 10-50× molar excess, whereas no effect was observed by the addition of 100-200× molar excess.
glands, submandibular glands, liver and spleen. Nuclear extracts from all five tissues were subsequently investigated for specific protein-binding to the fragments P1-P23 (Fig. 5D ) in gel retardation assays.
The resulting complex formations using fragments P14, P16 and P21 are shown in Figure 5A -C. The P16 and P14 fragments appear to be bound by nuclear complexes specific for PSP-expressing glands ( Fig. 5A and B, respectively) , whereas general complexes common to most or all of the investigated tissues seem to bind the P21 fragment (Fig. 5C) .
The tissue-specificity of nuclear complexes detected within the investigated region of the PSP gene is summarized in Figure 5D . Significantly, out of the 23 investigated fragments, six were capable of inducing gel shift unique to the PSP-expressing salivary glands indicating that they bind parotid and/or sublingual gland specific nuclear factors. Figure 5E indicates the position of the fragments (P1-P23) used in these gel retardation studies relative to the approximate location of the footprinted regions shown in Figure 3 .
Seven protein-binding elements within the proximal enhancer are recognized by parotid and sublingual gland specific nuclear complexes. Fragments A-M (Fig. 5E) were investigated for binding of nuclear factors from different tissues using the DNase I footprinting assay. Representative autoradiographs are shown in Figure 6 , which provides examples of different classes of protein-binding elements detected in the proximal PSP enhancer. Figure 6A shows the DNase I protection patterns of fragment D. Nuclear proteins isolated from all five investigated tissues Complex formation on the P21 fragment using 5 µg of nuclear extract in all lanes. Lachrymal gland (LA) nuclear extract was included in some DNA-binding assays because we observe PSP expression in this gland in certain mouse-strains. However, DNA-binding assays using lachrymal gland nuclear extract will not be discussed further here. DNA-protein complexes are indicated by arrows. (D) Schematic summary of DNA-protein interactions identified by gel retardation assays using nuclear extracts from the three mouse salivary glands, liver and spleen. The tissue-specificity of individual DNA-protein complexes was estimated by comparing the relative gel mobility of complexes detected with the five nuclear extracts. The drawing was made on the basis of results obtained using several independent preparations of both nuclear extracts and DNA fragments P1-P23. The relative arrangement and position of different complexes within a given fragment are arbitrary, and the presentation of detected complexes is simplified to emphasize apparent differences between PSP-expressing and non-expressing tissues. Filled ellipses symbolize complex-formation specific for the PSP-expressing salivary glands, empty ellipses represent general complex-formation and filled circles symbolize complex-formation specific for non-expressing tissues. seem to protect the XX region (approximately -3535 to -3570). Protection profiles provided by liver, spleen, submandibular and possibly sublingual nuclear proteins, however, are weak and/or different to that obtained with parotid gland nuclear proteins, suggesting that parotid gland nuclear proteins bind with high affinity and/or specificity to PSP sequences within the XX region.
The XIX region (approximately -3601 to -3636) is only protected by parotid gland nuclear proteins using fragment D (Fig. 6A) . Relatively higher concentrations of nuclear extract from other tissues did not reveal any protection of this region. In the gel retardation assay, however, nuclear extracts from all six tissues were able to complex with the 64 bp P14 fragment covering the XIX region, but different proteins appeared to be involved in complex formation in different tissues (Fig. 5B) . Thus, DNA-protein interactions seem to be altered in the context of the larger fragment, D, containing multiple binding sites.
Investigation of fragment B revealed one footprint, IX (from -4194 to approximately -4252), characterized by a very distinct, and at least partly unique, protection profile upon incubation with sublingual gland nuclear proteins (Fig. 6B) . The sublingual gland protection pattern of sequences spanning -4222 to -4239 seems to be reproduced with liver nuclear extracts, whereas sublingual gland protection of sequences flanking this region clearly differs from other nuclear extracts (Fig. 6B) .
Fragment J contains three (IV, V and VI) DNase I protected regions displaying tissue-specific protection profiles (Fig. 6C) . However, none of the footprints shown in Figure 6C are specific for the PSP-expressing salivary glands, but regions V and VI define a class of binding elements interacting with different nuclear complexes in the parotid gland and sublingual gland, respectively.
Most or all of the investigated nuclear extracts are able to protect the footprinted regions I-IV (Fig. 6D) with highly similar protection profiles, suggesting that these protein-binding elements are bound by general or ubiquitous nuclear factors.
The results of the DNase I footprinting analyses using nuclear extracts from PSP-expressing and non-expressing tissues are summarized in Figure 7B . Seven footprinted regions (IX, XII, XV, XVI, XIX, XX and XXIII) within the proximal PSP enhancer show parotid and/or sublingual gland specific DNase I protection profiles different from other investigated tissues. However, only two regions, XIX and IX, show unique protection by parotid gland and sublingual gland nuclear proteins, respectively.
The DNase I footprinting results essentially correlate with results obtained using the gel retardation assay (Figs 5D and E and 7). Together, these in vitro binding assays provide evidence for candidate parotid and/or sublingual gland specific binding elements within the proximal PSP enhancer region.
A 700 bp region is necessary to obtain Lama expression in transgenic mice
To delineate functionally important enhancer elements, we built two Lama constructs, Lama-∆Bsm and Lama-∆Sfi, deleted for PSP sequences upstream positions -4.3 and -3.6, respectively (Fig. 1A) . The effect of these proximal enhancer deletions was subsequently analyzed in transgenic mice.
As shown in Figure 1E , the Lama-∆Bsm construct is expressed in both the parotid and the sublingual glands of transgenic mice. The expression levels in both glands are similar to the level of Lama expression (Fig. 1A) . We observe expression in four out of eight lines in the sublingual glands and in four out of eight lines in the parotid glands (Fig. 1E and data not shown) . Thus, these Figure 5D , but emphasize tissue-specific differences detected in complex-formation between the parotid gland and the sublingual gland. (B) DNA elements characterized by tissue-specific protection patterns in the footprinting assay are illustrated by boxes, and the position of unique parotid gland (PG) or sublingual gland (SL) specific binding elements, binding elements protected specifically by both parotid and sublingual gland nuclear extracts (PS), and binding elements common to most or all investigated nuclear extracts (GEN) are indicated relative to the BsmI and SfiI restriction sites. Parotid and sublingual gland specific protein-binding elements overlapped by general protein-binding elements or binding elements characterized by complex tissue-specific protection patterns (CTP) are indicated by overlapping boxes. The two prominent protection profiles, XIX and IX, are designated PGE I and SLE I, respectively. Projected onto this scheme is the nucleotide sequence of the five enhancer elements located between -3.6 and -4. results indicate that the nuclear protein-binding elements, including V and VI, located between -4.3 and -4.6 kb relative to the transcription start site are of less or no functional importance for expression of Lama in PSP-expressing salivary glands.
The second deletion construct, Lama-∆Sfi, was analyzed for expression in six transgenic lines. However, transgenic expression could not be detected in the parotid nor the sublingual glands in these mice (Fig. 1F and data not shown) . We therefore conclude that Lama-∆Sfi lacks one or several important regulatory elements present in, and required for, expression of Lama-∆Bsm. Indeed, five parotid and sublingual gland specific binding elements, including XIX and XII, are located within the 700 bp proximal enhancer core region situated between -3.6 and -4.3 kb relative to the transcription initiation site (Fig. 7B) . Northern blotting analysis of submandibular gland, lachrymal gland, liver, spleen, kidney, heart and brain tissue from three transgenic lines carrying Lama-∆Bsm, and submandibular gland, lachrymal gland, liver, spleen, kidney, heart and abdominal wall tissue from two transgenic lines carrying Lama-∆Sfi did not reveal any ectopical expression (data not shown).
DISCUSSION
Salivary gland specific binding elements have been identified in 5′ flanking sequences of only a few salivary gland specific genes. The parotid gland specific regulation of the human amylase gene (AMY-1) is conferred by sequences (-1003 to -327) derived from an endogenous retroviral-like element (17) , whereas the salivary gland specific and cAMP inducible expression of the rat RP 4 gene is dependent on a salivary gland specific cAMP response element (SCRE) (-139 and -109) related to the E-box motif (18, 19) . The aim of the studies presented here was to delineate protein-binding elements involved in the regulation of the PSP gene.
We show that the region situated between -3.1 kb and -4.6 kb has properties of a parotid and sublingual specific enhancer. Thus, when analyzed in transgenic mice, this region is able to activate expression independent of its orientation and distance from the PSP promotor (Fig. 1) . We therefore designate the 1.5 kb upstream region as a PSP proximal enhancer.
DNA-binding studies identified a large number of potential protein-binding elements (Fig. 3) , suggesting a complex organization of the proximal PSP enhancer. A similar complexity has been described for other tissue-specific enhancers, including the 700 bp B-cell specific immunoglobin intron enhancer, containing 16 binding sites that regulate gene expression both positively and negatively (20) .
Transgenes containing the PSP promotor and 5′ flanking sequences up to position -3.6 kb were inactive in transgenic mice, whereas transgenes containing additional 5′ flanking sequences up to position -4.3 kb were able to direct salivary gland specific transcription (Fig. 1) . Therefore, the core region located between -3.6 kb and -4.3 kb contains sequence information necessary to direct salivary gland specific expression. Thus, positive-acting tissue-specific factors or complexes are likely to interact with this 700 bp region in the parotid gland and sublingual gland.
However, although the 700 bp core region is necessary to direct salivary gland specific and/or enhancer activity of the upstream region, it may not be sufficient for expression of the Lama construct. Sequence elements located downstream of the enhancer core region may also be essential for expression. Thus, the studies presented here do not rule out the possibility that sequences such as the XXIII region (Fig. 3) , which contains a potential conserved parotid gland element (PEI) (21) and the XX region, which is partly homologous to the XIX region (Figs 3 and 7B) , play significant roles in salivary gland specific PSP regulation.
Five protein-binding elements within the core region of the proximal enhancer were specific for one or both of the two PSP-expressing salivary glands (Fig. 7) . One class of interactions entails the XII, XV and XVI sequences, which are protected by parotid gland and/or sublingual gland nuclear extracts in a pattern different from other investigated nuclear extracts and include a number of potential binding sites, including potential E-box motifs, previously described in regulatory regions of other tissue-specific and salivary gland specific genes (Fig. 7) .
The other class of binding elements comprises the XIX and IX sequences. The XIX region is only protected by parotid gland nuclear extracts and represents a distinct parotid gland specific binding element within the PSP proximal enhancer (Fig. 6A) . Moreover, complex formation in the XIX region is likely to involve a context-dependent activity (compare Figs 5B and 6A) . Interestingly, the 5′ and 3′ sequences of the DNase I protected XIX region are homologous to the 5′ and 3′ sequences protected in the XX region (Fig. 3) , and both of these sequences are unrelated to the transcription factor consensus sites previously described (16) . It should be noted, however, that consensus factor binding sites, including octamer binding and homeodomain binding sites, are situated in XX as well as XIX (Fig. 3) . Cross-competition analysis demonstrated that binding of parotid gland proteins to the P14 fragment covering footprint XX could be competed for by the P16 fragment covering footprint XIX (Fig. 4B) . Thus, together these data suggest that the XIX and XX protein-binding sequences contain a similar binding element that may either represent a novel bipartite binding element or alternatively comprise binding sites for octamer binding factors. In any case, the protected sequences in the footprinted XIX and XX regions are not similar to regulatory binding elements described for other salivary gland specific genes. Sublingual gland nuclear extract was able to provide very distinct and at least partly unique protection of the IX sequences in the DNase I footprinting assay (Fig. 6B) . Moreover, the P6 fragment covering the IX region ( Fig. 5D and E) is bound by a sublingual gland specific complex in the gel retardation assay (Fig. 7A and data not shown) , thus supporting results from the DNase I footprinting assay. The protected sequences of the 50 bp IX region show homology to several previously described binding elements (Fig. 7B) , including consensus Pu.1, PEA3 and EI.2 protein-binding elements (22) (23) (24) , but none of these sequences are homologous to previously published salivary gland specific cis-elements.
In summary, the XIX and IX footprinted regions are only protected distinctly by parotid gland and sublingual gland nuclear extracts, respectively. This latter class of unique salivary gland specific binding elements represents likely candidates for important control regions in the PSP proximal enhancer and may also be part of the mechanism(s) that specify or direct the apparently differential mode of regulation in the two PSP-expressing salivary glands. These two novel salivary gland specific binding elements, XIX and XI, are therefore designated PGE I and SLE I, respectively.
